Pacira Pharmaceuticals, Inc. Business Finance Contracts & Agreements
52 Contracts & Agreements
- Assignment Agreements (2 contracts)
- Credit Agreements (1)
- Exchange Agreements (10)
- Guaranty Agreements (2)
- Indenture Agreements (6)
- Investor Rights Agreements (1)
- Loan Agreements (3)
- Note Agreements (1)
- Pledge Agreements (1)
- Security Agreements (2)
- Stock Agreements (11)
- Underwriting Agreements (4)
- Warrant Agreements (8)
- Form of Restricted Stock Unit Award Agreement under the Amended and Restated 2014 Inducement Plan (Filed With SEC on November 6, 2024)
- Form of Nonstatutory Stock Option Agreement under the Amended and Restated 2014 Inducement Plan (Filed With SEC on November 6, 2024)
- Indenture, dated as of May 14, 2024, by and between the Company and Computershare Trust Company, National Association (Filed With SEC on May 14, 2024)
- First Amendment, dated as of May 8, 2024, to Credit Agreement, dated as of March 31, 2023, by and among Pacira BioSciences, Inc., the lenders from time to time party thereto and... (Filed With SEC on May 8, 2024)
- Form of Restricted Stock Unit Award Agreement under the Amended and Restated 2014 Inducement Plan (Filed With SEC on February 29, 2024)
- Form of Nonstatutory Stock Option Agreement under the Amended and Restated 2014 Inducement Plan (Filed With SEC on February 29, 2024)
- Specimen Certificate Evidencing Shares of Common Stock (Filed With SEC on February 29, 2024)
- Amended and Restated 2014 Employee Stock Purchase Plan (Filed With SEC on June 10, 2022)
- First Supplemental Indenture, dated as of November 19, 2021, by and between Flexion Therapeutics, Inc. and Wells Fargo Bank, National Association, as trustee (Filed With SEC on February 28, 2022)
- Indenture (including form of 3.375% Convertible Senior Notes due 2024), dated as of May 2, 2017, by and between Flexion Therapeutics, Inc. and Wells Fargo Bank, National... (Filed With SEC on February 28, 2022)
- Contingent Value Right Agreement, dated as of November 19, 2021, by and between Pacira BioSciences, Inc. and American Stock Transfer & Trust Company, LLC (Filed With SEC on November 19, 2021)
- Indenture, dated as of July 10, 2020, by and between the Company and Wells Fargo Bank, National Association (Filed With SEC on July 10, 2020)
- Specimen Certificate Evidencing Shares of Common Stock (Filed With SEC on May 2, 2019)
- CONFIDENTIAL TREATMENT HAS BEEN REQUESTED FOR THE REDACTED PORTIONS OF THIS EXHIBIT. THE REDACTIONS ARE INDICATED WITH [**]. A COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED WITH... (Filed With SEC on May 4, 2017)
- PACIRA PHARMACEUTICALS, INC. and WELLS FARGO BANK, NATIONAL ASSOCIATION, as Trustee INDENTURE Dated as of March 13, 2017 2.375% Convertible Senior Notes due 2022 (Filed With SEC on March 13, 2017)
- CONFIDENTIAL TREATMENT HAS BEEN REQUESTED FOR THE REDACTED PORTIONS OF THIS EXHIBIT. THE REDACTIONS ARE INDICATED WITH [**]. A COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED WITH... (Filed With SEC on July 30, 2015)
- CONFIDENTIAL TREATMENT HAS BEEN REQUESTED FOR THE REDACTED PORTIONS OF THIS EXHIBIT. THE REDACTIONS ARE INDICATED WITH [**]. A COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED WITH... (Filed With SEC on April 30, 2015)
- CONFIDENTIAL TREATMENT HAS BEEN REQUESTED FOR THE REDACTED PORTIONS OF THIS EXHIBIT. THE REDACTIONS ARE INDICATED WITH [**]. A COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED WITH... (Filed With SEC on October 30, 2014)
- PACIRA PHARMACEUTICALS, INC. 2014 EMPLOYEE STOCK PURCHASE PLAN SECTION 1. PURPOSE (Filed With SEC on June 4, 2014)
- 1,600,000 Shares Pacira Pharmaceuticals, Inc. Common Stock UNDERWRITING AGREEMENT (Filed With SEC on April 9, 2014)
- CONFIDENTIAL TREATMENT HAS BEEN REQUESTED FOR THE REDACTED PORTIONS OF THIS EXHIBIT. THE REDACTIONS ARE INDICATED WITH [**]. A COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED WITH... (Filed With SEC on February 25, 2014)
- CONFIDENTIAL TREATMENT HAS BEEN REQUESTED FOR THE REDACTED PORTIONS OF THIS EXHIBIT. THE REDACTIONS ARE INDICATED WITH [**]. A COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED WITH... (Filed With SEC on February 25, 2014)
- Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions. PACIRA PHARMACEUTICALS, INC. and ARATANA... (Filed With SEC on March 7, 2013)
- Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions. EXCLUSIVE LICENSE, DEVELOPMENT AND... (Filed With SEC on March 7, 2013)
- PACIRA PHARMACEUTICALS, INC. and WELLS FARGO BANK, NATIONAL ASSOCIATION, as Trustee INDENTURE Dated as of January 23, 2013 3.25% Convertible Senior Notes due 2019 (Filed With SEC on January 23, 2013)
- WARRANT TO PURCHASE STOCK No. 4 (Filed With SEC on August 9, 2012)
- WARRANT TO PURCHASE STOCK No. 3 (Filed With SEC on August 9, 2012)
- WARRANT TO PURCHASE STOCK No. 2 (Filed With SEC on August 9, 2012)
- WARRANT TO PURCHASE STOCK No. 1 (Filed With SEC on August 9, 2012)
- Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote omissions. LOAN AND SECURITY AGREEMENT (Filed With SEC on August 9, 2012)
- 6,000,000 Shares Pacira Pharmaceuticals, Inc. Common Stock UNDERWRITING AGREEMENT (Filed With SEC on April 12, 2012)
- 6,000,000 Shares Pacira Pharmaceuticals, Inc. Common Stock UNDERWRITING AGREEMENT (Filed With SEC on November 10, 2011)
- Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote omissions. MASTER SERVICES AGREEMENT (Filed With SEC on October 31, 2011)
- Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote omissions. COMMERCIAL OUTSOURCING SERVICES AGREEMENT (Filed With SEC on October 31, 2011)
- [] Shares Pacira Pharmaceuticals, Inc. Common Stock UNDERWRITING AGREEMENT (Filed With SEC on January 13, 2011)
- WARRANT TO PURCHASE COMMON STOCK (Filed With SEC on January 3, 2011)
- WARRANT AGREEMENT To Purchase Shares of Preferred Stock of Pacira Pharmaceuticals, Inc. Dated as of November 24, 2010 (the Effective Date) (Filed With SEC on December 3, 2010)
- GUARANTY (Filed With SEC on December 3, 2010)
- LOAN AND SECURITY AGREEMENT (Filed With SEC on December 3, 2010)
- AMENDED AND RESTATED SECURITY AGREEMENT (SKPI) Dated as of March 23, 2007 between SKYEPHARMA INC., as Grantor, and ROYALTY SECURITIZATION TRUST I, as Purchaser TABLE OF CONTENTS (Filed With SEC on December 3, 2010)
